Sodium Citrate Blood-Pack Units, (PL 146 Plastic)
Sodium Citrate Blood-Pack Units, (PL 146 Plastic) is an FDA drug label for the active ingredient ANTICOAGULANT SODIUM CITRATE SOLUTION manufactured by Fenwal, Inc. administered by INTRAVENOUS. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20221107.
- Generic name
- ANTICOAGULANT SODIUM CITRATE SOLUTION
- Manufacturer
- Fenwal, Inc.
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Dosage form
- N/A
- NDC
- 0942-9506
- Application
- BN770923
- Label effective
- 20221107
About this product
Sodium Citrate Blood-Pack Units, (PL 146 Plastic) is an FDA-registered drug product whose active ingredient is ANTICOAGULANT SODIUM CITRATE SOLUTION. It is labelled by Fenwal, Inc. taken by intravenous and marketed as a human prescription drug product. Identifiers on file: NDC 0942-9506, application BN770923, label effective 20221107. It is one of 3 FDA drug label records sharing the active ingredient ANTICOAGULANT SODIUM CITRATE SOLUTION. This page reproduces the FDA-approved label text so you can check what a product is, who makes it and how it is supplied before discussing it with a pharmacist or prescriber.
How products containing ANTICOAGULANT SODIUM CITRATE SOLUTION compare
FDA lists 3 drug label records with ANTICOAGULANT SODIUM CITRATE SOLUTION as the active ingredient. The most common dosage forms and the manufacturers with the most records are summarised below; strengths, pack sizes and inactive ingredients can still differ between apparently similar products.
| Dosage form | Products | Manufacturer | Products |
|---|---|---|---|
| — | — | Fenwal, Inc. | 3 |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
Frequently asked questions
What is Sodium Citrate Blood-Pack Units, (PL 146 Plastic) used for?
No indications section is present in the FDA label on file for this product. Consult the prescribing information supplied with the medicine or ask a pharmacist.
Who makes Sodium Citrate Blood-Pack Units, (PL 146 Plastic)?
Fenwal, Inc. is the labeler of record for Sodium Citrate Blood-Pack Units, (PL 146 Plastic). 3 FDA label records share the active ingredient ANTICOAGULANT SODIUM CITRATE SOLUTION, so generic and branded versions may come from different companies; the manufacturer named on your pack is the one that matters for any enquiry.
What form does Sodium Citrate Blood-Pack Units, (PL 146 Plastic) come in?
administered by intravenous. Strengths and pack sizes vary by label, so compare the NDC on your pack with the identifier listed on this page.
Is Sodium Citrate Blood-Pack Units, (PL 146 Plastic) prescription or over-the-counter?
The FDA label for this product is recorded as human prescription drug. Marketing status can differ between strengths and countries, so check the dispensing rules where you live.
Are there other products containing ANTICOAGULANT SODIUM CITRATE SOLUTION?
Yes. 3 FDA drug label records list ANTICOAGULANT SODIUM CITRATE SOLUTION as the active ingredient. Products with the same active ingredient can usually be substituted only when a prescriber or pharmacist confirms it is appropriate.
Has Sodium Citrate Blood-Pack Units, (PL 146 Plastic) been recalled?
No FDA recall record in our database matches this product name or manufacturer. Recall data is updated periodically, so a very recent notice may not appear here yet.
Where does this information come from?
All content is reproduced from FDA Structured Product Labelling data via openFDA. It is provided for identification and reference only and is not medical advice.
This page reproduces FDA Structured Product Labelling data for identification and reference. It is not medical advice, does not diagnose or treat any condition, and does not sell or price any medicine.